ArticleBioinformatics (Oxford, England)2025
Spatial transcriptomics deconvolution methods generalize well to spatial chromatin accessibility data.
Article in Bioinformatics (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Multi-task spatial distillation reveals cell-type-resolved programmed cell death landscapes in the human kidney.Briefings in bioinformatics · 2026Article
- Local Tumor Microenvironment Niches Correlate With Survival And Immunotherapy Response In Human Glioblastoma.bioRxiv : the preprint server for biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
motivationSpatially resolved chromatin accessibility profiling offers the potential to investigate gene regulatory processes within the spatial context of tissues. However, current methods typically work at spot resolution, aggregating measurements from multiple cells, thereby obscuring cell-type-specific spatial patterns of accessibility. Spot deconvolution methods have been developed and extensively benchmarked for spatial transcriptomics, yet no dedicated methods exist for spatial chromatin accessibility, and it is unclear if RNA-based approaches are applicable to that modality.
resultsHere, we demonstrate that these RNA-based approaches can be applied to spot-based chromatin accessibility data by a systematic evaluation of five top-performing spatial transcriptomics deconvolution methods. To assess performance, we developed a simulation framework that generates both transcriptomic and accessibility spot data from dissociated single-cell and targeted multiomic datasets, enabling direct comparisons across both data modalities. Our results show that Cell2location and RCTD, in contrast to other methods, exhibit robust performance on spatial chromatin accessibility data, achieving accuracy comparable to RNA-based deconvolution. Generally, we observed that RNA-based deconvolution exhibited slightly better performance compared to chromatin accessibility-based deconvolution, especially for resolving rare cell types, indicating room for future development of specialized methods. In conclusion, our findings demonstrate that existing deconvolution methods can be readily applied to chromatin accessibility-based spatial data. Our work provides a simulation framework and establishes a performance baseline to guide the development and evaluation of methods optimized for spatial epigenomics. AVAILABILITY AND IMPLEMENTATION: All methods, simulation frameworks, peak selection strategies, analysis notebooks and scripts are available at https://github.com/theislab/deconvATAC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.